Skip to content

The effectiveness of acupoint herbal patching for patients receiving intravesical instillation therapy after transurethral resection of the bladder

The effectiveness of acupoint herbal patching for patients receiving intravesical instillation therapy after transurethral resection of the bladder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074736
Enrollment
Unknown
Registered
2023-08-15
Start date
2023-08-13
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

A:The first routine bladder infusion treatment, and the second bladder infusion treatment after applying traditional Chinese medicine acupoints before infusion
B:For the first time, traditional Chinese medicine acupoint application was used before infusion, followed by bladder infusion therapy. For the second time, routine bladder infusion therapy was perfor

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who diagnosed as non-muscle invasive bladder tumor. 2. Patients who have undergone transurethral resection of bladder tumor. 3. Patients who are receiving intravesical instillation therapy after transurethral resection of the bladder, with a frequency of once a week for two consecutive weeks. 4. Patients who sign the informed consent form and volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to complete intravesical instillation therapy. 2. Patients with communication barriers. 3. Patients with indwelling urinary catheters. 4.Patients who need to change the drug during intravesical instillation therapy.

Design outcomes

Primary

MeasureTime frame
EORTC QLQ-C30;FACT-BL;

Countries

China

Contacts

Public ContactLei Shi

The Second Hospital of Hebei Medical University

1074163894@qq.com+86 185 3113 9936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026